Anonymous
Guest
Anonymous
Guest
Did I just read that email right? Just how many primary care docs treat schizophrenia?
I don't think there will be much change other than who is being reported to. Because Fanapt is in "Primary Care" aka GenMeds, it just means that management reports to Nikos instead of someone else. Makes little sense to have too much high level management especially for some of the divisions, like Neuro, that is making very little money.
Another smoke and mirrors announcement. More layoffs ahead. Just think of how this was done in the same way last year and 2 years ago. Same BS. Roll in another sales force, then "right-size" everyone. I am on the Fanapt side and now will be looking for a job. The writing is definitely on the wall. Way to go Novartis, another cluster-f__k.
I don't think there will be much change other than who is being reported to. Because Fanapt is in "Primary Care" aka GenMeds, it just means that management reports to Nikos instead of someone else. Makes little sense to have too much high level management especially for some of the divisions, like Neuro, that is making very little money.
Primary Care Doc "keeping a schz patient coming back"? You are an idiot. They don't want them in the office. Most are on 3 to 6 psyche drugs (often super high doses). Way out of their realm of experience. Most don't have the ability to keep an appointment unless there is someone taking care of them. Patients often dissheveled, poor hygiene and delusional etc. that freaks out other people in waiting room. They don't get better, just worse. A horrible disease with bad outcomes.
I don't think there will be much change other than who is being reported to. Because Fanapt is in "Primary Care" aka GenMeds, it just means that management reports to Nikos instead of someone else. Makes little sense to have too much high level management especially for some of the divisions, like Neuro, that is making very little money.